Snapshot from Aug 03, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical conference

Immatics PRAME presentations at ESMO 2026

Analysis based on 6 articles · First reported Jul 17, 2026 · Last updated Jul 17, 2026

Sentiment
10
Attention
2
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The announcement may positively impact Immatics' stock as it showcases progress in its PRAME pipeline. However, the event is a routine conference presentation, so market impact is likely limited.

biotechnology pharmaceutical

Immatics announced three presentations at the ESMO Congress 2026, to be held in Madrid, Spain from October 23-27, 2026. The presentations will cover Phase 1b data from anzu-cel in melanoma, Phase 1 data from IMA203CD8 across solid tumors, and Phase 1b data from IMA402 bispecific at RP2D range. These highlight the breadth of Immatics' PRAME franchise across cell therapies and bispecifics.

70 Immatics announced presentations
stock
Immatics is the company presenting data at ESMO, highlighting its PRAME franchise.
Importance 100.0 Sentiment 10.0
ngo
ESMO is the host of the congress where Immatics will present.
Importance 10.0 Sentiment 0.0
stock
Moderna is mentioned as a collaborator for a combination therapy with anzu-cel.
Importance 5.0 Sentiment 0.0
per
Winfried Alsdorf is a presenting author of a poster on anzu-cel.
Importance 5.0 Sentiment 0.0
per
Antonia Busse is a presenting author of an oral presentation on IMA203CD8.
Importance 5.0 Sentiment 0.0
per
Dirk Schadendorf is a presenting author of a rapid oral presentation on IMA402.
Importance 5.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.